NCT00047827View on ClinicalTrials.gov

Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for Aspergillosis

PHASE2TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

February 28, 2003

Study Completion Date

February 28, 2003

Conditions
Aspergillosis
Interventions
DRUG

Micafungin

IV

DRUG

Liposomal Amphotericin B

IV

Trial Locations (7)

20010

Washington D.C.

30322

Atlanta

38105

Memphis

48109

Ann Arbor

48201

Detroit

63110

St Louis

77030

Houston

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY